CD44 and lip and oral cavity carcinoma: The BeVigilantTM Rapid Test (Vigilant Biosciences, Florida, FL, USA) is a CE-approved POC IVD, which qualitatively identifies the presence of soluble CD44 (sCD44) and total protein levels in patients at risk of oral cancer.